Lifevantage (NASDAQ:LFVN) Given New $8.00 Price Target at Freedom Broker

Key Points

• Freedom Broker cut its Lifevantage price target from $9 to $8 but maintained a Buy rating, implying 64.27% upside from the stock’s then-current price.
• Analyst sentiment overall was more cautious: Lifevantage had a consensus Hold rating and average price target of $6.33, with one Buy, two Hold, and one Sell rating.
• The company missed quarterly expectations, reporting EPS of $0.05 versus $0.06 expected and revenue of $37.12 million versus a $40.49 million consensus estimate.

Lifevantage (NASDAQ:LFVN - Get Free Report) had its target price cut by Freedom Broker from $9.00 to $8.00 in a research note issued to investors on Friday, Benzinga reports. The brokerage currently has a "buy" rating on the stock. Freedom Broker's target price would indicate a potential upside of 64.27% from the company's current price.

Other analysts have also issued reports about the company. Lake Street Capital raised their target price on Lifevantage from $5.00 to $6.00 and gave the company a "hold" rating in a research note on Friday, August 28th. Zacks Research cut Lifevantage from a "hold" rating to a "strong sell" rating in a report on Friday, October 16th. Finally, Weiss Ratings reaffirmed a "hold (c)" rating on shares of Lifevantage in a research note on Friday, August 21st. One equities research analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Lifevantage has an average rating of "Hold" and a consensus price target of $6.33.

Lifevantage Stock Performance

Lifevantage stock traded down $0.17 during trading hours on Friday, hitting $4.87. 95,891 shares of the stock were exchanged, compared to its average volume of 213,792. The stock has a market capitalization of $61.76 million, a P/E ratio of 23.29 and a beta of 0.71. The business's 50-day moving average is $5.95 and its two-hundred day moving average is $5.86. Lifevantage has a 12 month low of $3.90 and a 12 month high of $11.71.

Lifevantage (NASDAQ:LFVN - Get Free Report) last posted its earnings results on Monday, November 9th. The company reported $0.05 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.06 by ($0.01). The firm had revenue of $37.12 million during the quarter, compared to the consensus estimate of $40.49 million. Lifevantage had a net margin of 1.58% and a return on equity of 16.35%. On average, equities analysts predict that Lifevantage will post 0.39 earnings per share for the current fiscal year.

Insider Activity

In other news, insider Kristen Cunningham sold 8,901 shares of the business's stock in a transaction on Monday, September 14th. The shares were sold at an average price of $6.18, for a total value of $55,008.18. Following the completion of the transaction, the insider owned 120,162 shares of the company's stock, valued at $742,601.16. The trade was a 6.90% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 13.58% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Engineers Gate Manager LP increased its holdings in shares of Lifevantage by 109.7% in the second quarter. Engineers Gate Manager LP now owns 27,009 shares of the company's stock worth $169,000 after acquiring an additional 14,131 shares in the last quarter. Bank of New York Mellon Corp bought a new position in shares of Lifevantage during the 2nd quarter valued at about $78,000. Bank of America Corp DE lifted its holdings in shares of Lifevantage by 24.3% during the 1st quarter. Bank of America Corp DE now owns 23,445 shares of the company's stock valued at $101,000 after purchasing an additional 4,586 shares in the last quarter. Finally, Hsbc Holdings PLC acquired a new position in shares of Lifevantage in the 1st quarter valued at approximately $51,000. 35.32% of the stock is currently owned by institutional investors.

Lifevantage Company Profile

LifeVantage Corporation is a health and wellness company that develops, markets and distributes dietary supplements and personal-care products. Its product portfolio is designed to support areas such as cellular health, antioxidant defenses, energy, nutrition and skin care. The company's principal brands have included Protandim, a line of dietary supplements; TrueScience, a skin-care and wellness brand; and Petandim, products formulated for pets. LifeVantage primarily uses a direct-selling business model, distributing its products through independent sales representatives and online channels.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.